NCT01073202View on ClinicalTrials.gov

Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

January 31, 2009

Conditions
Liver TransplantationIschemia-reperfusion InjuryCholestasis
Interventions
DRUG

ursodeoxycholic acid

13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation

DRUG

identical-appearing placebo

13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation

Trial Locations (1)

200080

Shanghai First People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01073202 - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation | Biotech Hunter | Biotech Hunter